SGT-94

N/A

Report date: 2024/09/26 15:34:02

Base Information

Drug NameSGT-94
Drug Alias NameSGTRB94TfRscFv/Lip/RB94RB94 lipoplex gene therapy (Synergene/MD Anderson)SGT RB94SGT-RB94 +[6] 
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionTransferrin receptor protein 1 stimulantsTumor protein p53 modulators
TargetsTransferrin receptor protein 1Tumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynergene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynergene Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A